Delayed Drug Approval Costs Drug Producers Billions Says Expert

Eric Sun, Ph.D at Stanford University says that drug producers could save billions of dollars by getting prescription drugs immediately approved instead of going through a delayed process. (0:26)
Listen

Delayed Drug Approval Destroying Drug Producers' Sales Says Scientist

Tomas Philipson, Ph.D. at the University of Chicago says that the main cost for drug producers are the forgotten profits of delayed sales. (0:11)
Listen

Patients Suffering The Most From FDA Regulations, Says Scientist

Tomas Philipson, Ph.D. at the University of Chicago says FDA regulations are causing delays in drug development, hurting patients more than it costs the producers. (0:17)
Listen

Mikulski: The Pandemic of Drug Demand

Chairwoman of Senate Committee on Appropriations Barbara Mikulski (D-Md.) compares the current drug problems the U.S faces to the H1N1 pandemic, and this "insatiable demand" only helps to fund enemies abroad, like the Taliban and Mexican drug cartels. (0:35)
Listen

Napolitano: Mexican Drug Cartel Violence A Threat To U.S. Homeland Security

By Kayleigh Harvey - Talk Radio News Service

At a Senate Judiciary Committee hearing today on "Southern Border Violence: Homeland Security Threats, Vulnerabilities and Responsibilities," Secretary for the U.S. Department of Homeland Security, Janet Napolitano agreed with a question posed by Committee Chairman, Senator Joseph Liberman (D-Conn.) on threats to U.S. homeland security. Senator Liberman asked whether, as Secretary of Homeland and Security, she considered Mexican drug cartel violence a real threat to the homeland security of the United States.
Listen